157 related articles for article (PubMed ID: 29374212)
1. Tissue Factor-bearing MPs and the risk of venous thrombosis in cancer patients: A meta-analysis.
Cui CJ; Wang GJ; Yang S; Huang SK; Qiao R; Cui W
Sci Rep; 2018 Jan; 8(1):1675. PubMed ID: 29374212
[TBL] [Abstract][Full Text] [Related]
2. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
3. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
5. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
6. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
8. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
Uszyński W; Zekanowska E; Uszyński M; Zyliński A; Kuczyński J
Thromb Res; 2013; 132(6):757-60. PubMed ID: 24157083
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
Geddings JE; Mackman N
Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.
Zwicker JI; Liebman HA; Neuberg D; Lacroix R; Bauer KA; Furie BC; Furie B
Clin Cancer Res; 2009 Nov; 15(22):6830-40. PubMed ID: 19861441
[TBL] [Abstract][Full Text] [Related]
11. Annexin V
Chen Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Cao X; Zhang W; Liu L; Wu J
Clin Chim Acta; 2022 Nov; 536():169-179. PubMed ID: 36191610
[TBL] [Abstract][Full Text] [Related]
12. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
13. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.
Auwerda JJ; Yuana Y; Osanto S; de Maat MP; Sonneveld P; Bertina RM; Leebeek FW
Thromb Haemost; 2011 Jan; 105(1):14-20. PubMed ID: 21057704
[TBL] [Abstract][Full Text] [Related]
14. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk.
Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N
Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893
[TBL] [Abstract][Full Text] [Related]
15. Deep venous thrombosis.
López JA; Kearon C; Lee AY
Hematology Am Soc Hematol Educ Program; 2004; ():439-56. PubMed ID: 15561697
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients.
Thaler J; Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):127-31. PubMed ID: 21792463
[TBL] [Abstract][Full Text] [Related]
17. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.
Basavaraj MG; Olsen JO; Østerud B; Hansen JB
Thromb Res; 2012 Sep; 130(3):538-46. PubMed ID: 22728024
[TBL] [Abstract][Full Text] [Related]
18. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
19. Role of tissue factor in venous thrombosis.
Manly DA; Boles J; Mackman N
Annu Rev Physiol; 2011; 73():515-25. PubMed ID: 20690821
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis.
Aass HC; Øvstebø R; Trøseid AM; Kierulf P; Berg JP; Henriksson CE
Cytometry A; 2011 Dec; 79(12):990-9. PubMed ID: 21990118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
